Immunogenic compositions containing n-glycol ylneuraminic acid bearing nanoparticles
AssigneeRamot at Tel-Aviv University Ltd.
InventorsVered PADLER-KARAVANI, Eliran Moshe REUVEN, Shani LEVIATAN BEN-ARYE
Life of this patent
Estimating the term…
Abstract
The present invention provides an active cancer vaccine and specifically an immunogenic compositions of membrane vesicles that serve as biomimetic nanoparticles derived from eukaryotic cell membranes that bear N-glycolylneuraminic acid glycoconjugates. These compositions can elicit beneficial immunological responses for treatment of Neu5Gc-positive tumors. The present invention provides methods of generating and using Neu5Gc-conjugated nanoparticles from eukaryotic cells membranes designated nano-ghosts.
Claims27
1-36. (canceled)
An immunogenic composition comprising a plurality of membrane vesicles bearing N-glycolylneuraminic acid (Neu5Gc) glycoconjugates;
- wherein the Neu5Gc glycoconjugates are exposed on the outer surface of the membrane vesicles;
- wherein said membrane vesicles are derived from the outer plasma membrane of a eukaryotic cell expressing Neu5Gc;
- and
- wherein the membrane vesicles have an average hydrodynamic diameter in the submicron range.
A method for preparing cell ghosts bearing Neu5Gc-glycoconjugates, the method comprising the steps of:
- a) providing a first composition comprising a plurality of isolated eukaryotic cells expressing Neu5Gc glycoconjugates on the outer membrane surface;
- b) rupturing the cell membrane of said eukaryotic cells by exposure to a hypotonic buffer followed by centrifugation to remove soluble proteins, thereby obtaining a second composition;
- and
- c) washing the second composition and resuspending in double distilled water to obtain the cell ghosts bearing Neu5Gc-glycoconjugates.
Dependencies are inferred from the claim text.